Back to search
FDAFDA · Food and drugs·Recall number D-0871-2017

morphine sulfate in 0.9% Sodium Chloride injectable, 1 mg per mL, Total Volume 100 mL, Single Dose Container bag, (Total morphine Dose 100 mg/ 100 mL), Preservative Free (Contains Sulfites), Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR 72205, NDC 70004-0100-55

Published June 7, 2017 · Recall initiated: May 18, 2017

Summary

FDA records drug Class II recall D-0871-2017, published June 7, 2017 and initiated May 18, 2017. Recalling firm: SCA Pharmaceuticals; Status: Terminated; Reported quantity: 56 bags; Lot: LOT # 20170508@48, Use By: 08/06/17; 20170505@19, Use By: 08/03/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility: Product bags leaking at seam.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SCA Pharmaceuticals
Distributor
Nationwide in the USA
Lot
LOT # 20170508@48, Use By: 08/06/17; 20170505@19, Use By: 08/03/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was morphine sulfate in 0.9% Sodium Chloride injectable, 1 mg per mL, Total Volume 100 mL, Single Dose Container bag, (Total morphine Dose 100 mg/ 100 mL), Preservative Free (Contains Sulfites), Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct, Little Rock, AR 72205, NDC 70004-0100-55 recalled?

Yes. FDA published recall D-0871-2017 on June 7, 2017. Reported hazard: Lack of assurance of sterility: Product bags leaking at seam.

What should I do if I have this product?

Voluntary: Firm initiated · Letter